- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01910753
Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population (APANVADS)
September 6, 2016 updated by: University Hospital, Limoges
Feasibility Study: Physical Activity Program Associated Wtih Nutrition Therapeutic Education in Head and Neck Cancer Population Treating by Chemotherapy With or Without Radiotherapy.
The purpose of this study is to examine the feasibility of resistance training and physical functioning associated with nutrition therapeutic education in head and neck cancer patients, during their treatment (chemotherapy with or without radiotherapy).
Study Overview
Detailed Description
The loss of muscle mass (i.e., sarcopenia) has been identified as a negative prognosis descriptor, disregarding the type of cancer.
It is also a predictive descriptor for treatment-related toxicity.
Therefore it appears crucial to save muscle mass of patients, following an adequate physical training together with a personalised diet program.
The latter point is of major importance as malnutrition concerns 45% patients having head and neck cancer cancer, who stop physical activity due to extreme tiredness and decrease of quality of life.
In the present project, we plan a physical activity program that would be adapted to each patient, accompanied by the rethought diet over a 3-month period.
The adapted physical activity (APA) is constituted of two aerobic stages and one resistance training stage per a week.
The evaluation will then proceed at three different moments, namely (i) at T0 i.e., beginning of the program, (ii) at 3 months i.e., when the program will be stopped, and (iii) at 6 months i.e., three months after the program stop.
This evaluation will include the success rate, the level of satisfaction, the physiological parameters (VO2max, muscle mass and strength, BMI) and quality of life.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Limoges, France, 87042
- CHU LIMOGES - Explorations Fonctionnelles Respiratoires
-
Limoges, France, 870
- CHU LIMOGES - Oncologie
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age>18 years
- Written informed consent provided before any study specific procedures
- Consent to cooperate for clinical assessments
- Affiliation to a social security regime or beneficiary of equivalent social protection
- Performance status between 0 and 2
- Squamous cell carcinoma of oral cavity, oropharynx or hypopharynx
- Stage III - IV (T1-T4, N0-N3, M)(UICC 2002)
- Indication of radiotherapy and chemotherapy post-operative or first-line metastatic chemotherapy or in inoperable condition
- Ability to understand the nature, goal and study methodology
Exclusion Criteria:
- Prior neoadjuvant chemotherapy
- timed vital capacity< 70%
- Presence of another severe pathology including:
- severe or chronic cardiac, pulmonary, renal and/or hepatic insufficiencies
- Cons-indication to physical activity practice, at discretion of the investigator
- Patient under guardianship
- Psychological, social, geographical, or familial reasons prohibiting physical activity and follow-up
- Any other primary tumor during the last 5 years
- Pregnant or nursing
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: APA
Patient with neck cancer and accepting the physical activity program .
|
A 3-month program for physical activity and diet education will be followed.
An exercise specialist will supervise patients twice per week, during the first six weeks.
They will also follow nutrition counselling and therapeutic education by a dietician once per week.
During the last six weeks, they will just follow a guide for safe and appropriate exercise regimen.
The dietician will call patient weekly during this final period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
feasibility of the APA with a composite outcome measure
Time Frame: 3 months
|
The evaluation criteria for the PA program will be:
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of the personalised diet program and the therapeutic education with a composite outcome measure.
Time Frame: 3 months
|
The evaluation criteria for the personalised diet program and the therapeutic education will be:
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: FRANCOIS Vincent, MD, Limoges UH
- Principal Investigator: Sabrina FALKOWSKI, MD, CHU LIMOGES - Oncologie
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
June 1, 2015
Study Registration Dates
First Submitted
July 22, 2013
First Submitted That Met QC Criteria
July 25, 2013
First Posted (Estimate)
July 30, 2013
Study Record Updates
Last Update Posted (Estimate)
September 7, 2016
Last Update Submitted That Met QC Criteria
September 6, 2016
Last Verified
September 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I12018 APANVADS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neck Cancer
-
Robert FerrisAmgenCompletedHead and Neck Cancer | Cancer of Head and Neck | Head Cancer | Neck Cancer | Neoplasms, Head and Neck | Cancer of the Head and Neck | Cancer of Neck | Upper Aerodigestive Tract Neoplasms | Neck Neoplasms | Cancer of the Head | Cancer of the Neck | UADT Neoplasms | Cancer of Head | Head Neoplasms | Head, Neck Neoplasms | Neoplasms, Head and other conditionsUnited States
-
Mayo ClinicCompletedCancer Head Neck | Cancer Neck | Cancer, HeadUnited States
-
West China HospitalNot yet recruitingHead and Neck Cancer | Malignant Neoplasm | Advanced Head and Neck Carcinoma | Head &Amp; Neck Cancer
-
Assiut UniversityRecruitingHead and Neck Cancer | Head and Neck Neoplasms | Cancer of Head and Neck | Neoplasms, Head and Neck | Cancer of the Head and NeckEgypt
-
Stanford UniversityNational Cancer Institute (NCI)CompletedHead Neck CancerUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompleted
-
Rigshospitalet, DenmarkHerlev HospitalUnknown
-
Rigshospitalet, DenmarkCopenhagen University Hospital at HerlevUnknown
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH)CompletedHead Neck CancerUnited States
-
East and North Hertfordshire NHS TrustRecruiting
Clinical Trials on APA
-
GERCOR - Multidisciplinary Oncology Cooperative...Active, not recruitingMetastatic Pancreatic Cancer | Unresectable Locally Advanced CancerFrance
-
Centre Hospitalier Régional Metz-ThionvilleUniversity of LorraineRecruitingAnxiety | Hematological Malignancies | Relaxation | Adapted Physical ActivityFrance
-
Centre Henri BecquerelCompleted
-
Centre Hospitalier Universitaire de BesanconGERCOR - Multidisciplinary Oncology Cooperative GroupRecruiting
-
Universite du Littoral Cote d'OpaleUniversity Hospital, Lille; AFM Telethon; Fondation Maladies Rares (French Foundation...Not yet recruiting
-
Centre Hospitalier Universitaire de BesanconNot yet recruitingMenopausal Depression | Depression - Major Depressive DisorderFrance
-
Chang Gung UniversityCompleted
-
Johns Hopkins UniversityCompletedAromatase Inhibitor | Musculoskeletal Symptoms | Postmenopausal Breast Cancer SurvivorsUnited States
-
Centre Antoine LacassagneCentre Hospitalier Universitaire de NiceNot yet recruitingBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Gastric Adenocarcinoma | Ovarian AdenocarcinomaFrance
-
University of Ljubljana, Faculty of MedicineRecruitingChildren | Adults | Missing Incisors | Zirconia Surface Pretreatment | DebondingSlovenia